Cross-Border Impact Ventures (CBIV) has recently announced the successful closing of its Women’s and Children’s Health Technology Fund, raising over $90 million in investor commitments. The fund is dedicated to investing in technology companies that address the health needs of women, children, and adolescents, and also aims to enhance the resilience of health systems. Based in North America and Europe, CBIV targets…
Portfolia, a U.S.-based venture capital firm known for its diverse investment portfolio, recently announced the launch of FemTech Fund III, a new investment vehicle focusing on women’s health. This fund, the third of its series, reflects the firm’s dedication to the women’s health and femtech sectors. Founded by Trish Costello in 2014, Portfolia stands out in the venture capital world with its…
New York-based venture capital firm Black Opal Ventures (BOV) has launched a health-tech fund aimed at advancing the healthcare sector through technology. The fund, co-founded by MIT alumnae Dr. Tara Bishop and Eileen Tanghal, has raised $58M to date and has attracted capital from major institutions like Eli Lilly and Company, Bank of America, and others. Black Opal Ventures’ primary focus is…
Sofinnova Partners, a European venture capital firm with bases in Paris, London, and Milan, has announced the closing of its “Sofinnova Digital Medicine I” fund, amassing $200M (€190M). This new fund represents the largest early-stage digital medicine fund in Europe, surpassing its initial fundraising target. The fund, led by Edward Kliphuis and Simon Turner, aims to advance the digital healthcare sector. It…
In an era where the digital transformation of healthcare has become increasingly imperative, 7wireVentures is taking a substantial step forward in supporting high-potential companies that are leading the charge. The venture capital firm, known for its commitment to fostering innovation in the healthcare sector, has recently raised a new investment vehicle – a $217M Growth & Opportunity Fund (GO Fund). The new…
According to The Wall Street Journal, FemHealth Ventures has closed a $32M fund dedicated to investments in women’s health innovation. While the fundraising efforts exceeded their initial goal, they fell short of the $50 million hard cap due to challenges faced by the new venture firm during its inaugural fundraise. FemHealth Ventures maintains a strong emphasis on supporting companies in the fields…
age1, a venture capital firm specializing in longevity biotech, launched earlier this week in San Francisco announcing an initial closing fund of $35M. The firm aims to radically shift the paradigm from sick care to health preservation and lifespan extension. Backed by a specialized team with a track record, age1 was co-founded by Laura Deming, founder of The Longevity Fund, and Dr.…
Questa Capital has closed its third fund, Questa Capital Partners III, LP (“Fund III”), amassing $397M in capital commitments. This brings the firm’s total committed capital to over $1 billion, in support of its focus on modernizing the healthcare industry. The new fund aims to invest in growth companies across three core healthcare sectors: services, technology, and medical devices. Led by Founder…
